Using RevTet-On System to Control Thrombopoietin Gene Expression
- Author:
Xudong WEI
1
;
Shuang FU
;
Weiping ZANG
;
Shasha WU
;
Shenwu WANG
;
Debing WANG
Author Information
1. Institute of Hematology, People's Hospital, Peking University, Beijing 100044, China.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2000;8(4):241-244
- CountryChina
- Language:Chinese
-
Abstract:
For the purpose of thrombocytopenia gene therapy, recombinant RevTet-On and pRevTRE/TPO retrovirus were packaged and transfected to NIH3T3 after selected with G418 and hygromycin, the two inserting recombinant retrovirus cell strain RevTet-On3T3/TPO were established. TPO expression was controlled and regulated by doxycydine (Dox). After using Dox to control the expression of TPO in RevTet-On3T3/TPO cells, the result showed that when Dox is added to the RevTet-On3T3/TPO cells, cell populations expressed TPO highly in the presence of 2 mg/L of Dox, and lowly in the absence of Dox. By using the RevTet-On gene expression system (the retrovirus vector RevTet-On regulation system to control the expression gene by Dox), it could modulate the expression of multiple genes by tetracyline and its derivatives. This system maybe provides a safe and efficacient way for the thrombocy to penia gene therapy.
